Gene Therapy Market: By Development Phase; By Applications & By Geography - Forecast 2016-2021

  • ID: 3973909
  • Report
  • 147 pages
  • IndustryARC
1 of 3
Gene therapy can be defined as the treatment of a disease by modifying, replacing, or supplementing a genetic combination that is absent or abnormal and is responsible for causing causing the disease. Gene therapy has emerged as one of the most sought after research objectives in order to cure incurable diseases. Globally increasing instances of HIV, Cancer and other difficult to cure diseases is driving the demand for gene therapy.

This report identifies the gene therapy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to gene therapy market.

Globally North America dominated the market for gene therapy in 2015 with highest market share due to higher research and development activities by pharmaceutical industry in the region. North America was followed by Asia-Pacific as the second largest regional market for gene therapy due to higher faster growing pharma industry which is investing heavily in research and development activities for advanced treatment. Asia-Pacific is also expected to remain fastest growing regional segment during the period of study due to increasing presence of global giants from pharma industry in the region.

This report on global gene therapy covers different type of gene therapy developments, applications of gene therapy in curing diseases and market size in various geographical regions.

The report covers also cover gene therapy market developments from the development phase perspective as follows: Phase I, Phase II, Phase III
On the basis of applications of gene therapy, this report also covers all the major applications of gene therapy in curing major diseases, some of the major diseases covered in this report are as follows: Oncology, Infectious Diseases, Genetic Disorders, Cardiovascular Disorders, Diabetes Mellitus, Neurological Disorders and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for gene therapy in each of the region.

This report identifies all the major companies operating in the global gene therapy market. Some of the major companies’ profiles in detail are as follows:

American Gene Technologies International
Applied Genetic Technologies Corporation
Asklepios BioPharmaceutical
AnGes MG
Urigen Pharmaceuticals
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Gene Therapy – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Gene Therapy – Market Forces
4.1. Drivers
4.1.1. Increasing reported cases of HIV, Cancer and cystic fibrosis
4.2. Restraints
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Gene Therapy Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Gene Therapy Market, By Development Phase
6.1. Phase I
6.2. Phase II
6.3. Phase III

7. Gene Therapy Market, By Applications
7.1. Oncology
7.2. Infectious Diseases
7.3. Genetic Disorders
7.4. Cardiovascular Disorders
7.5. Diabetes Mellitus
7.6. Neurological Disorders
7.7. Others

8. Global Gene Therapy Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Gene Therapy – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
10.1. American Gene Technologies International
10.2. Applied Genetic Technologies Corporation
10.3. Asklepios BioPharmaceutical
10.4. AnGes MG
10.5. Urigen Pharmaceuticals
10.6. BioSante Pharmaceuticals
10.7. Oxford BioMedica
10.8. Genzyme Corporation
10.9. ReGenX Biosciences
10.10. Sangamo BioSciences
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown